Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday.
The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500 also fell, dropping, 0.63% to 4,425.66.
Check This Out: Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Leading and Lagging Sectors
Utilities shares fell by just 0.2% on Tuesday.
In trading on Tuesday, consumer discretionary shares dipped by 1.4%.
Top Headline
Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020.
Equities Trading UP
Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) shares shot up 17% to $9.86. The FDA granted an investigational device exemption to initiate BACKBEAT Study evaluating Orchestra biomed's atrioventricular interval modulation therapy (BACKBEAT CNT) for hypertensive patients who are indicated for a dual-chamber cardiac pacemaker.
Shares of Avinger, Inc. (NASDAQ: AVGR) got a boost, shooting 62% to $9.83, adding to outsized gains from Monday. On Monday, Avinger shares soared 46.8% after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
Elutia Inc. (NASDAQ: ELUT) shares were also up, gaining 29% to $1.60 after the company announced the sale of its Orthobiologics business unit to Berkeley Biologics LLC. Elutia announced $26 million private placement of 7,355,869 shares of common stock at $1.4275 per share.
Equities Trading DOWN
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP) shares dropped 20% to $0.89. 60 Degrees Pharmaceuticals’ subsidiary, 60P Australia Pty Ltd, has withdrawn its investigational new drug (IND) application for ACLR8-LR, a Phase 2B study of the use of tafenoquine in treating COVID-19.
Shares of Histogen Inc. (NASDAQ: HSTO) were down 38% to $0.4101 as the company reported board approval of complete liquidation and dissolution.
Revance Therapeutics, Inc. (NASDAQ: RVNC) was down, falling 29% to $11.78. Revance Therapeutics commenced a plan to exit the OPUL payments business, citing that significant costs and resources required to support OPUL no longer align with the company’s capital allocation priorities.
Also Check This Out: Ocean Power Technologies And 3 Other Stocks Under $1 Insiders Are Buying
Commodities
In commodity news, oil traded up 1.4% to $92.72 while gold traded up 0.1% at $1,955.80.
Silver traded down 0.2% to $23.455 on Tuesday while copper fell 0.9% to $3.7435.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 fell 0.15% London’s FTSE 100 rose 0.01% while Spain’s IBEX 35 Index rose 0.48% The German DAX fell 0.49% French CAC 40 fell 0.09%, while Italy’s FTSE MIB Index gained 0.47%.
Annual inflation rate in the Eurozone was revised lower to 5.2% in August versus an initial reading of 5.3%, recording the lowest reading since Jan. 2022. The Eurozone posted a current account surplus of €26.9 billion in July versus a €15.8 billion deficit in the year-ago month.
Italy's current account surplus widened to EUR 5.156 billion in July from EUR 0.795 billion in the year-ago month.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan’s Nikkei 225 falling 0.87%, Hong Kong’s Hang Seng Index rising 0.37% and China’s Shanghai Composite Index falling 0.03%.
Hong Kong's unemployment rate came in unchanged at 2.8% during the three months ending Aug. 2023.
Economics
The FOMC will start its two-day policy meeting today.
Housing starts in the U.S. fell 11.3% month-over-month to an annualized rate of 1.283 million in August, recording the lowest level since June 2020.
Building permits rose 6.9% to an annual rate of 1.543 million in August, notching the highest level in 10 months.
Now Read This: Top 5 Energy Stocks That You May Want To Dump In September
COVID-19 Update
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 108,479,200 cases with around 1,175,350 deaths. India confirmed a total of at least 44,998,210 cases and 531,930 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 695,437,400 cases of COVID-19 worldwide with more than 6,916,330 deaths.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.